Novacyt S.A. (“Novacyt”, the “Company” or the “Group”) Notice of rescheduled AGM AGM to be held online on Thursday 18 July Paris, France, and Eastleigh and Manchester, UK – 26 June 2024 - Novacyt...
Novacyt S.A. (“Novacyt”, the “Company” or the “Group”) Publication of Annual Report Paris, France, and Eastleigh and Manchester, UK – 14 June 2024 - Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international...
Novacyt S.A. (“Novacyt”, the “Company” or the “Group”) Settlement of the dispute with the DHSC Paris, France, and Eastleigh and Manchester, UK – 11 June 2024 - Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM:...
Novacyt S.A. (“Novacyt”, the “Company” or the “Group”) AGM Voting Paris, France, and Eastleigh and Manchester, UK – 3 June 2024 -Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international molecular diagnostics company...
Novacyt S.A. (“Novacyt”, the “Company” or the “Group”) Full Year 2023 results Integration of Yourgene Health remains on track Laying the foundations for future growth Paris, France, and Eastleigh and Manchester, UK – 30 May...
Novacyt S.A. (“Novacyt”, the “Company” or the “Group”) Notice of Results and Annual General Meeting Paris, France, and Eastleigh and Manchester, UK – 20 May 2024 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM:...
Novacyt S.A. (“Novacyt”, the “Company” or the “Group”) DHSC application for summary judgment dismissed Paris, France, and Eastleigh and Manchester, UK – 1 May 2024 – Following the announcement on 19 April 2024,...
Novacyt S.A. (“Novacyt”, the “Company” or the “Group”) Long Term Incentive Plan 2024 Performance Share Awards Paris, France, and Eastleigh and Manchester, UK – 23 April 2024 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM:...
Novacyt S.A. (“Novacyt”, the “Company” or the “Group”) DHSC Claim update – Pre-Trial Review Paris, France, and Eastleigh and Manchester, UK – 19 April 2024 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT),...
Novacyt S.A. (“Novacyt”, the “Company” or the “Group”) Directorate changes and full year 2023 results update Lyn Rees appointed CEO Dr. Joanne Mason, CSO, to join the Board Paris, France, and Eastleigh and Manchester, UK...
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
